Skip to content
Disclosery

Braslyn Ltd.

Follow

13F filer, CIK 1642355, NEW PROVIDENCE, Bahamas

Braslyn Ltd. reported $7,812,816 across 1 holding for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-25-000061

Period
2024-12-31
Reported value
$7.81M
Holdings
1
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TNGXexited-26,961-$208K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0000895345-25-000061, largest first. % of portfolio is the value over $7,812,816, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSGINSEEGO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 761,483 shares; 2024Q4: 761,483 shares 761,483$7.81M100%0Timeline

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TNGXTANGO THERAPEUTICS INC26,961$208Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-25-000061 base2025-02-14acceptance time not in the bulk data set